| 摘要 |
This application encompasses novel prodrugs of triciribine and related compounds and therapeutic regimens of prodrugs of triciribine and related compounds and compositions for the treatment of tumors, cancer, and other disorders associated with abnormal cell proliferation. The application further encompasses oral formulations of prodrugs with increased bioavailabilty, which allows a new route of administration with the attendant clinical benefits of ease of administration. |
